Sign in

or Register now

MyBreastCancerNetwork.com

See all of our health sites at www.HealthCentral.com
Thursday, November 12, 2009
  • Font size
  • Bookmark
  • Save

Avastin for Breast Cancer

Avastin went from being rejected as a breast cancer treatment by an FDA advisory in December 2007, due to its toxicity and side effects in patients, to being accepted by the FDA in late February 2008 as a treatment for women with advanced (metastatic) breast cancer. Find patient advice and stories, as well as focused news coverage of Avastin.

Avastin for Breast Cancer Patients

  • Meet PJ Hamel
    Learn More About Avastin
    Avastin (bevacizumab) is the first FDA-approved drug that inhibits angiogenesis, or the formation of new blood vessels in support of tumor growth.
  • The Cost of Avastin: Extending Life, Growing Genentech Stock Price?
    Avastin, with its cutting-edge ability to starve cancerous tumors by throttling their blood supply, is expected to be one of the world’s top-selling drugs. Its approval is viewed as a possible lowering in standards for approval of certain cancer drugs. Is it worth it?
  • Balancing Avastin's Potential and Problems: A Survivor's Thoughts
    When the news broke December 5 that an FDA expert panel had voted 5-4 to reject Avastin (bevacizumab) as an approved breast cancer treatment because of serious side effects, I experienced a moment of deep sadness, as well as some frustration.

NBCC's Take on Avastin

A Patient's Experience with Avastin

Keri Haberstroh's Treatment for Metastatic Breast Cancer at Age 26

Keri Starts Avastin for breast cancer

Learn More About Keri Haberstroh

  • keri breast cancer 83
    Breast Cancer at Age 25
    Keri was only 25 when she was first diagnosed with invasive / infiltrating ductal carcinoma. The cancer was diagnosed as metastatic, having spread to her sacrum, when Keri was 26.
  • Font size
  • Bookmark
  • Save